Process Industries

Kaneka Corp.

In the news

Japan reveals 87 projects eligible for 'China exit' subsidies Jul 18, 2020
Avigan ingredient shortage hits Japan stockpile plan Apr 17, 2020
Spiking caustic soda demand burns Japan's waterworks and papermakers Mar 7, 2018
Japan's suppliers eagerly eye market for foldable smartphones Feb 12, 2018
How China's fight against pollution is pressuring disposable diaper makers Jan 5, 2018

Business Summary

Kaneka Corp. engages in the manufacture and sale of chemicals, synthetic resins, and plastics. It operates through the following segments: Material Solutions, Quality of Life Solutions, Health Care Solutions, Nutrition Solutions and Others. The Material Solutions segment covers biodegradable polymers, materials that support the development of social infrastructure and mobility which includes the weight reduction and fuel efficiency improvement. The Quality of Life Solutions segment handles energy saving needs such as housing and living infrastructure, and development of Internet of things (IoT) and artificial intelligence (AI). The Health Care Solutions segment offers solutions through the fusion of devices and medicines, and develops healthcare business based on biopharmaceuticals and regenerative and cellular medicines. The Nutrition Solutions segment provides materials and supplement solutions to food production support in livestock and fishery industries. The Others segment provides agency services for property and life insurance. The company was founded on September 1, 1949 and is headquartered in Osaka, Japan.

Financial Highlights

Mar 2022	JPY	USD
Revenue	691,530M	6,153.89M
Gross Profit	190,432M	1,694.64M
Operating income	43,564M	387.67M
Income before tax	36,405M	323.96M
Net income	26,488M	235.71M
EBITDA	82,074M	730.37M
Diluted EPS	404.96	3.60
Dividends Per Share	110	0.97
Total Assets	726,959M	5,989.36M
Total liabilities	314,752M	2,593.21M
Total equity	387,769M	3,194.80M
Operating cash flow	34,106M	303.50M
	Currency in JPY	Currency in USD

Historical Data

JPY | USD

	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022
Revenue	596,142M	621,043M	601,514M	577,426M	691,530M
Gross Profit	163,939M	169,419M	162,222M	160,907M	190,432M
Operating income	36,252M	36,042M	24,972M	27,545M	43,564M
Income before tax	31,085M	31,909M	19,797M	22,201M	36,405M
Net income	21,572M	22,239M	14,004M	15,831M	26,488M
EBITDA	67,104M	68,646M	59,856M	64,351M	82,074M
Diluted EPS	328.05	338.60	214.28	242.13	404.96
Dividends Per Share	90	100	100	100	110
Total Assets	639,780M	659,587M	653,262M	667,429M	726,959M
Total liabilities	293,178M	298,859M	299,164M	286,387M	314,752M
Total equity	326,487M	337,424M	331,966M	357,616M	387,769M
Operating cash flow	49,750M	41,113M	39,983M	74,040M	34,106M

	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022
Revenue	5,378.76M	5,600.29M	5,532.39M	5,444.46M	6,153.89M
Gross Profit	1,479.16M	1,527.74M	1,492.02M	1,517.16M	1,694.64M
Operating income	327.08M	325.01M	229.67M	259.71M	387.67M
Income before tax	280.46M	287.74M	182.08M	209.33M	323.96M
Net income	194.63M	200.54M	128.80M	149.26M	235.71M
EBITDA	605.45M	619.01M	550.52M	606.75M	730.37M
Diluted EPS	2.96	3.05	1.97	2.28	3.60
Dividends Per Share	0.81	0.90	0.91	0.94	0.97
Total Assets	6,015.79M	5,959.13M	6,051.24M	6,040.08M	5,989.36M
Total liabilities	2,756.72M	2,700.08M	2,771.19M	2,591.73M	2,593.21M
Total equity	3,069.92M	3,048.50M	3,075.04M	3,236.34M	3,194.80M
Operating cash flow	448.87M	370.73M	367.74M	698.11M	303.50M

Valuation Measures

Mar 2022
PER	8.73
ROA	3.79%
ROE	7.10%
Operating margin	6.29%
Profit margin	3.83%

Key executives

President & Representative Director: Minoru Tanaka
Director, Head-Investor Relations & Finance: Shinobu Ishihara
Director, Senior Executive Officer & Head-Research: Mamoru Kadokura
Director, VP, Head-Raw Materials & Personnel: Shinichiro Kametaka
Director, VP & Head-New Business Development: Kazuhiko Fujii

Shareholders

Sumitomo Mitsui Trust Asset Management Co., Ltd. (6.7%)
Nippon Life Insurance Co. (4.5%)
Sumitomo Mitsui Financial Group, Inc. (4.5%)
Mitsubishi UFJ Financial Group, Inc. (4.2%)
Meiji Yasuda Life Insurance Co. (4.1%)
Kaneka Corp. (4.0%)
MS&AD Insurance Group Holdings, Inc. (3.0%)
The Vanguard Group, Inc. (2.1%)
Nomura Asset Management Co., Ltd. (2.0%)
Eastspring Investments (Singapore) Ltd. (1.9%)

Contact Details

Website:http://www.kaneka.co.jp
Address: Nakanoshima Festival Tower, 35/F, 2-3-18 Nakanoshima, Osaka, 530-8288, Japan
Phone: +81.6.6266.5050

Related Companies

Kyushu Kanelite Co., Ltd.
Kaneka Nishinippon Styrol Co., Ltd.
Kaneka Chubu Styrol Co., Ltd.
Kaneka Kanto Styrol Co., Ltd.
Kaneka Tohoku Styrol Co., Ltd.
Kaneka Solar Marketing Corp.
Nagashima Shokuhin Co., Ltd.
Kaneka Hokkaido Corp.
Kaneka Your Health Care Co., Ltd.
OLED Aomori Co., Ltd.
Cemedine Sales Co., Ltd.
Kaneka MS Malaysia Sdn. Bhd.
Cemedine North America LLC
Eurogentec North America, Inc.
TGA Pastry Co. Pty Ltd.
Showa Global Ltd.
Kaneka (Thailand) Co., Ltd.
Dalian Showa Plastic Co., Ltd.
Eurogentec Nederland BV
Eurogentec Proteomics GmbH
Eurogentec Deutschland GmbH
Kaneka Medical Tech Corp.
Kaneka Foam Plastics Co., Ltd.
Kaneka Pension Fund
Showa Global (Thailand) Co., Ltd
Kaneka Employee Incentive Plan
Kaneka Europe Holding Co. NV
Vienex Corp.
Kaneka Medical Vietnam Co., Ltd.
Kaneka Taiwan Corp.

Competitors

Avantium N.V.
Huntsman Corporation
Shandong Ruifeng Chemical Co., Ltd. Class A
Danimer Scientific, Inc. Class A
Rayitek Hi-Tech Film Company Ltd., Class A
Taimide Tech, Inc.
CytoSorbents Corporation
GeneOne Life Science, Inc.
Yield10 Bioscience, Inc.

Last Updated on 16 Aug, 2022